← Eichor
Study identifier: NCT05390892 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

Condition: Type2Diabetes · ASCVD  ·  Sponsor: Brigham and Women's Hospital

PhasePhase 4
Planned participants6000
Who can joinAll sexes, 40 Years to 80 Years
Healthy volunteersNo

About this study

PRECIDENTD is a randomized, open label, pragmatic clinical trial designed to compare rates of the total number of cardiovascular, kidney, and death events among two alternative treatments for patients with type 2 diabetes (T2D) and either established atherosclerotic cardiovascular disease (ASCVD) or at high risk for ASCVD. To accomplish this objective, we will randomly assign 6,000 patients with established T2D and ASCVD or high-risk for ASCVD in a 1:1 allocation to sodium-glucose cotransporter-2 inhibitor (SGLT2i) or glucagon-like peptide-1 receptor agonists (GLP-1RA). Participants will be followed for the occurrence of the trial primary endpoint of the total (first and recurrent) number of episodes of myocardial infarction (MI), stroke, arterial revascularization, hospitalization for heart failure, development of end-stage kidney disease, kidney transplantation, and mortality, counting all events from randomization until end of study.

This description comes directly from the study's public registry record.

Talk to the study team

Brendan Everett, MD, MPH  ·  617-732-8790  ·  PRECIDENTDccc@bwh.harvard.edu

Maureen Malloy  ·  617-732-8773  ·  PRECIDENTDccc@bwh.harvard.edu

Always discuss trial participation with your own doctor first.

Locations (36)

Longwood Research LLCHuntsville, Alabama, United StatesRecruiting
HonorHealth Research & Innovation InstituteScottsdale, Arizona, United StatesRecruiting
Eastside Clinical Research AssociatesLos Angeles, California, United StatesRecruiting
Kendall South Medical Center, IncMiami, Florida, United StatesRecruiting
South Florida Research Solutions, LLCPembroke Pines, Florida, United StatesRecruiting
NSC Research, Inc.Johns Creek, Georgia, United StatesRecruiting
Herman Clinical ResearchSuwanee, Georgia, United StatesRecruiting
University of Illinois ChicagoChicago, Illinois, United StatesRecruiting
Rush University Medical CenterHinsdale, Illinois, United StatesRecruiting
University of IowaIowa City, Iowa, United StatesRecruiting
University of Kansas Medical CenterFairway, Kansas, United StatesRecruiting
Johns Hopkins School of MedicineBaltimore, Maryland, United StatesRecruiting

+ 24 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05390892